Disease | graft versus host disease |
Symptom | C0026946|fungal infections |
Sentences | 2 |
PubMedID- 22215361 | Purpose: the results of a pharmacoeconomic study of the cost-effectiveness of posaconazole versus fluconazole in preventing invasive fungal infections (ifis) in patients with graft-versus-host disease (gvhd) are reported. |
PubMedID- 21694893 | Another international study by ullmann et al in 2007 looked at prophylaxis against invasive fungal infections in patients with graft-versus-host disease (gvhd) on immunosuppressive treatment and compared posaconazole with fluconazole.24 this was a randomized, double-blind trial including patients who received an allogeneic hematopoietic stem cell transplant and developed gvhd. |
Page: 1